Alector Inc
ALEC1.508USD
+0.058+3.97%
交易中 （美東）報價延遲15分鐘
150.74M總市值
虧損本益比TTM
關於 Alector Inc 公司
Alector, Inc. 是一家臨牀階段的生物技術公司。該公司專注於免疫神經學，這是一種治療神經退行性疾病的新型治療方法。該公司致力於開發旨在通過恢復大腦健康免疫功能同時對抗這些病理的療法。其研究和藥物發現平臺利用人類基因數據集、生物信息學和成像方面的先進工具以及神經退行性疾病和免疫學方面的見解來識別免疫系統。其候選產品：latozinemab (AL001)、AL002 和 AL101 正在臨牀開發中。其免疫神經學候選產品得到生物標誌物的支持，並尋求治療包括阿爾茨海默病和基因定義的額顳葉癡呆患者羣體在內的適應症。其第一個候選產品 latozinemab 是一種人重組單克隆抗體，可增加 FTD-GRN 患者大腦中的前顆粒蛋白 (PGRN) 水平。
公司簡介
公司代碼ALEC
公司名稱Alector Inc
上市日期Feb 07, 2019
CEODr. Arnon Rosenthal, Ph.D.
員工數量238
證券類型Ordinary Share
年結日Feb 07
公司地址131 Oyster Point Blvd., Suite 600
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94080
電話14152315660
網址https://alector.com
公司代碼ALEC
上市日期Feb 07, 2019
CEODr. Arnon Rosenthal, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.58M
+2.52%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
156.08K
+53.99%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
60.41K
+84.69%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
56.41K
+103.58%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
53.91K
+113.85%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
39.01K
+278.29%
Mr. Giacomo Salvadore, M.D.
Mr. Giacomo Salvadore, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Louis J. (Lou) Lavigne, Jr.
Mr. Louis J. (Lou) Lavigne, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Errol De Souza, Ph.D.
Dr. Errol De Souza, Ph.D.
Independent Director
Independent Director
--
--
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.58M
+2.52%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
156.08K
+53.99%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
60.41K
+84.69%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
56.41K
+103.58%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
53.91K
+113.85%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
39.01K
+278.29%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月14日 週三
更新時間: 5月14日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.39%
Polaris Venture Partners
9.85%
RA Capital Management, LP
9.70%
BlackRock Institutional Trust Company, N.A.
6.41%
The Vanguard Group, Inc.
6.05%
Other
53.59%
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.39%
Polaris Venture Partners
9.85%
RA Capital Management, LP
9.70%
BlackRock Institutional Trust Company, N.A.
6.41%
The Vanguard Group, Inc.
6.05%
Other
53.59%
股東類型
持股股東
佔比
Investment Advisor
34.87%
Venture Capital
21.09%
Investment Advisor/Hedge Fund
13.63%
Hedge Fund
8.42%
Individual Investor
7.06%
Corporation
3.55%
Research Firm
2.88%
Pension Fund
0.22%
Bank and Trust
0.08%
Other
8.20%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
372
91.63M
91.64%
-20.36M
2025Q1
390
94.05M
94.69%
-22.49M
2024Q4
384
95.68M
96.58%
-16.24M
2024Q3
380
93.59M
96.08%
-7.82M
2024Q2
378
93.92M
97.44%
-5.66M
2024Q1
379
96.98M
102.83%
+4.66M
2023Q4
382
85.51M
101.07%
-5.87M
2023Q3
384
84.61M
100.28%
-2.32M
2023Q2
384
80.93M
96.65%
-6.40M
2023Q1
391
80.04M
96.46%
-3.77M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Fidelity Management & Research Company LLC
14.39M
14.39%
-299.63K
-2.04%
Mar 31, 2025
Polaris Venture Partners
9.85M
9.85%
--
--
Sep 30, 2024
RA Capital Management, LP
9.70M
9.7%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.41M
6.41%
-393.95K
-5.79%
Mar 31, 2025
The Vanguard Group, Inc.
6.05M
6.05%
+453.75K
+8.10%
Mar 31, 2025
Rosenthal (Arnon)
5.44M
5.44%
-52.09K
-0.95%
Jun 02, 2025
Merck & Co Inc
3.55M
3.55%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
1.96M
1.96%
+47.85K
+2.50%
Mar 31, 2025
State Street Global Advisors (US)
1.64M
1.64%
-209.03K
-11.30%
Mar 31, 2025
J.P. Morgan Securities LLC
1.45M
1.45%
-159.71K
-9.94%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.47%
iShares Neuroscience and Healthcare ETF
0.27%
iShares Micro-Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Biotechnology ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 2000 ETF
0%
Fidelity MSCI Health Care Index ETF
0%
JPMorgan Fundamental Data Science Small Core ETF
0%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.47%
iShares Neuroscience and Healthcare ETF
佔比0.27%
iShares Micro-Cap ETF
佔比0.03%
Invesco Nasdaq Biotechnology ETF
佔比0.02%
ProShares Ultra Nasdaq Biotechnology
佔比0.02%
iShares Biotechnology ETF
佔比0.01%
iShares Russell 2000 Value ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0%
Fidelity MSCI Health Care Index ETF
佔比0%
JPMorgan Fundamental Data Science Small Core ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
